Search / Trial NCT06227988

ASSESSMENT OF SURGICAL RISK IN PATIENTS WITH CHRONIC LIVER DISEASE USING VOCAL PENN SCORE

Launched by ASIAN INSTITUTE OF GASTROENTEROLOGY, INDIA · Jan 19, 2024

Trial Information

Current as of December 22, 2024

Recruiting

Keywords

Fluid Buildup In The Belly (Ascites) Gallstones. Muscle Loss.

ClinConnect Summary

This clinical trial is looking at how well a specific scoring system, called the VOCAL PENN score, can predict the risk of dying after surgery in patients with chronic liver disease, specifically those with cirrhosis. The researchers want to compare this new score with an existing system called MELD to see which one is more accurate in predicting the chances of survival 30 and 90 days after surgery.

To be eligible for this trial, participants need to be adults aged 65 years and older who have been diagnosed with cirrhosis and are planning to undergo certain types of abdominal surgeries. Patients who have had a liver transplant, those who are having multiple surgeries at once, or those who cannot provide enough medical information will not be included. If you join the study, you’ll have your risk assessed using the VOCAL PENN score before your surgery, and the researchers will follow up with you afterward to see how you are doing. This trial is currently recruiting participants, and it aims to improve the way we understand surgical risks in people with chronic liver disease.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with established cirrhosis Patients who had not received liver transplantation and who underwent surgery of interest were included These surgery categories will be the same as those used in the original VOCAL-Penn derivation study and will include the open abdominal, laparoscopic abdominal, and abdominal wall.
  • Exclusion Criteria:
  • Patients with insufficient pre-operative data to compute the VOCAL-Penn score, Mayo risk score, or MELD-Na score will be excluded.
  • Patients undergoing liver surgeries Patients who received multiple surgeries Those who didn't give consent

Trial Officials

PRACHITI Gokhe

Principal Investigator

AIG HOSPITALS

About Asian Institute Of Gastroenterology, India

The Asian Institute of Gastroenterology (AIG) in India is a premier healthcare institution specializing in advanced gastroenterology and hepatology. Renowned for its commitment to clinical excellence and innovative research, AIG conducts a range of clinical trials aimed at enhancing the understanding and treatment of gastrointestinal and liver disorders. With a multidisciplinary team of experienced clinicians and researchers, the institute leverages state-of-the-art technology and patient-centered approaches to contribute significantly to the advancement of medical knowledge and improved patient outcomes in the field of gastroenterology.

Locations

Hyderabad, Telangana, India

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0